{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:06:53Z","timestamp":1793984813915,"version":"4.8.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NeoTract\/Teleflex, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41391-018-0118-x","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T17:11:34Z","timestamp":1544634694000},"page":"411-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study"],"prefix":"10.1038","volume":"22","author":[{"given":"Daniel","family":"Rukstalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Tutrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euclid","family":"deSouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Kamientsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Eure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"118_CR1","unstructured":"Roehrborn CG, McConnel JD, Barry MJ, Benaim E, Bruskewitz RC, Blute ML et al. Guideline on the management of benign prostatic hyperplasia. USA: American Urological Association Education and Research, Inc; 2003."},{"key":"118_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1557988313510732","volume":"8","author":"MJ Schoenfeld","year":"2014","unstructured":"Schoenfeld MJ, Shortridge EF, Gelwicks SC, Cui Z, Wong DG. Treatment patterns in alpha-blocker therapy for benign prostatic hyperplasia. Am J Men\u2019s Health. 2014;8:267\u201372.","journal-title":"Am J Men\u2019s Health"},{"key":"118_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2014.09.001","volume":"193","author":"A Bachmann","year":"2015","unstructured":"Bachmann A, Tubaro A, Barber N, d\u2019Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transuerethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015;193:570\u20138.","journal-title":"J Urol"},{"key":"118_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.juro.2018.05.048","volume":"200","author":"HE Foster","year":"2018","unstructured":"Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA. et al.Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline.J Urol. 2018;200:612\u20139.","journal-title":"J Urol"},{"key":"118_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","volume":"13","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med. 2016;13:924\u201333.","journal-title":"J Sex Med"},{"key":"118_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","volume":"21","author":"D Mollengarden","year":"2018","unstructured":"Mollengarden D, Goldberg K, Wong D, Roehrborn CF. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostatic Cancer Prostatic Dis. 2018;21:379\u201385.","journal-title":"Prostatic Cancer Prostatic Dis"},{"key":"118_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore N, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195:1529\u201338.","journal-title":"J Urol"},{"key":"118_CR8","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.juro.2013.05.116","volume":"190","author":"CG Roehrborn","year":"2013","unstructured":"Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190:2162\u20137.","journal-title":"J Urol"},{"key":"118_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bju.12540","volume":"113","author":"AL Cantwell","year":"2013","unstructured":"Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, et al. Multicentre prospective crossover study of the \u2018prostatic urethral lift\u2019 for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2013;113:615\u201322.","journal-title":"BJU Int"},{"key":"118_CR10","first-page":"7094","volume":"21","author":"N Shore","year":"2014","unstructured":"Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014;21:7094\u2013101.","journal-title":"Can J Urol"},{"key":"118_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J Sonksen","year":"2015","unstructured":"Sonksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643\u201352.","journal-title":"Eur Urol"},{"key":"118_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.urology.2011.10.021","volume":"79","author":"PT Chin","year":"2012","unstructured":"Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79:5\u201311.","journal-title":"Urology"},{"key":"118_CR13","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24:8802\u201313.","journal-title":"Can J Urol"},{"key":"118_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.urology.2008.09.055","volume":"73","author":"CK Doo","year":"2009","unstructured":"Doo CK, Uh HS. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS. Urology. 2009;73:232\u20136.","journal-title":"Urology"},{"key":"118_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4293\/108680813X13693422519910","volume":"17","author":"SK Shah","year":"2013","unstructured":"Shah SK, Fleet T, Skipper B. Urinary symptoms after robotic prostatectomy in men with median lobes. JSLS. 2013;17:529\u201334.","journal-title":"JSLS"},{"key":"118_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1464-410X.2003.04088.x","volume":"91","author":"SJ Chia","year":"2003","unstructured":"Chia SJ, Heng CT, Chan SP, Foo KT. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91:371\u20134.","journal-title":"BJU Int"},{"key":"118_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.urology.2004.10.014","volume":"65","author":"H Nose","year":"2005","unstructured":"Nose H, Foo KT, Lim KB, Yokoyama T, Ozawa H, Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology. 2005;65:493\u20137.","journal-title":"Urology"},{"key":"118_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1590\/S1677-55382008000500012","volume":"34","author":"LO Reis","year":"2008","unstructured":"Reis LO, Barreiro GC, Baracat J, Prudente A, D\u2019Ancona CA. Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction. Int Braz J Urol. 2008;34:627\u201337.","journal-title":"Int Braz J Urol"},{"key":"118_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.urology.2007.08.008","volume":"70","author":"Z Keqin","year":"2007","unstructured":"Keqin Z, Zhishun X, Jing Z, Haixin W, Dongqing Z, Benkang S. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement. Urology. 2007;70:1096\u20139.","journal-title":"Urology"},{"key":"118_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4111\/kju.2013.54.6.369","volume":"54","author":"SH Shin","year":"2013","unstructured":"Shin SH, Kim JW, Kim JW, Oh MM, Moon DG. Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol. 2013;54:369\u201372.","journal-title":"Korean J Urol"},{"key":"118_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4111\/kju.2012.53.7.472","volume":"53","author":"JH Wee","year":"2012","unstructured":"Wee JH, Choi YS, Bae WJ, Kim SJ, Cho HJ, Hong SH, et al. Influence of intravesical prostatic protrusion on preoperative lower urinary tract symptoms and outcomes after 120 w high performance system laser treatment in men with benign prostatic hyperplasia. Korean J Urol. 2012;53:472\u20137.","journal-title":"Korean J Urol"},{"issue":"4S","key":"118_CR22","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1016\/j.juro.2018.02.2003","volume":"199","author":"Z Gul","year":"2018","unstructured":"Gul Z, Chughtai B, Te A, Kaplan S. Ejaculatory preserving middle lobe only\u2014transurethral resection and vaporization of the prostate: 12 year experience. J Urol. 2018;199(4S):e832.","journal-title":"J Urol"},{"key":"118_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3310\/hta12350","volume":"12","author":"T Lourenco","year":"2008","unstructured":"Lourenco T, Armstrong N, N\u2019Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess. 2008;12:169\u2013515. iii,ix-x, 1-146","journal-title":"Health Technol Assess"},{"issue":"6 Pt 1","key":"118_CR24","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/01.ju.0000127761.87421.a0","volume":"171","author":"B Hill","year":"2004","unstructured":"Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004;171(6 Pt 1):2336\u201340.","journal-title":"J Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0118-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-018-0118-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:47Z","timestamp":1684618427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-018-0118-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1038\/s41391-018-0118-x","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]},"assertion":[{"value":"13 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GE, DR, DG and JK are NeoTract\/Teleflex, Inc. consultants. SS works with the US Navy\/Department of Defense.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}